132 related articles for article (PubMed ID: 5201592)
1. [Biological half-life of fibrinogen labelled with radioactive iodine I-131 in coronary disease].
Dordević BS; Bosnjaković V; Baklaja-Jevremović R; Nastić D
Acta Med Iugosl; 1970; 24(1):7-19. PubMed ID: 5201592
[No Abstract] [Full Text] [Related]
2. [Effect of heparin and pelentan on the biopolymer metabolism of connective tissue in myocardial infarct].
Sharaev PN; Leshchinskiĭ LA; Pimenov LT; Vtorov AE
Farmakol Toksikol; 1984; 47(1):44-6. PubMed ID: 6705903
[TBL] [Abstract][Full Text] [Related]
3. [Myocardial infarct as a stochastic manifestation].
Drdková S; Zaloudek M
Cesk Zdrav; 1969; 17(10):437-9. PubMed ID: 5343835
[No Abstract] [Full Text] [Related]
4. [Blood sterol-fibrinogen complexes in chronic ischemic heart disease].
Revutskiĭ EL; Palamarchuk VI; Vendt VP; Fedorishko SS
Vrach Delo; 1979 Sep; (9):43-5. PubMed ID: 494607
[No Abstract] [Full Text] [Related]
5. [A new anticoagulant: ethyldicoumarol 75].
Warembourg H; Ducloux G
Lille Med; 1968 Mar; 13(3):Suppl:257-9. PubMed ID: 5759685
[No Abstract] [Full Text] [Related]
6. Lowering fibrinogen levels: clinical update. BIP Study Group. Bezafibrate Infarction Prevention.
Behar S
Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S41-3. PubMed ID: 10070817
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes.
Abrignani MG; Novo G; Di Girolamo A; Caruso R; Tantillo R; Braschi A; Braschi GB; Strano A; Novo S
Cardiologia; 1999 Dec; 44(12):1047-52. PubMed ID: 10687254
[TBL] [Abstract][Full Text] [Related]
8. [Concentration of vitamin A in blood and its relation to the content of proteins, cholesterin and beta-lipoproteids in the blood of patients with atherosclerosis].
Zhelezovskaia IB
Vopr Med Khim; 1969; 15(5):506-12. PubMed ID: 5368088
[No Abstract] [Full Text] [Related]
9. Immunologic study of fibrinogen and its split products in venous thrombosis.
Sova J
Acta Univ Carol Med Monogr; 1972; 52():173-9. PubMed ID: 4593289
[No Abstract] [Full Text] [Related]
10. [Thrombogenesis in atherosclerosis of the coronary arteries].
Petrova TP; Pavlishchuk SA
Ter Arkh; 1968 Jan; 40(1):41-5. PubMed ID: 5747054
[No Abstract] [Full Text] [Related]
11. Blood coagulability and lipid metabolism in patients with coronary insufficiency.
Panchenko VM; Bazaz'yan GG
Fed Proc Transl Suppl; 1966; 25(5):800-2. PubMed ID: 5223562
[No Abstract] [Full Text] [Related]
12. A variant of beta fibrinogen is a genetic risk factor for coronary artery disease and myocardial infarction.
Yu Q; Safavi F; Roberts R; Marian AJ
J Investig Med; 1996 Apr; 44(4):154-9. PubMed ID: 8689411
[TBL] [Abstract][Full Text] [Related]
13. [Anticoagulant therapy with "regulated hypocoagulation of the blood" in the initial period of myocardial infarct].
Gritsiuk AI; Petrus' VG
Kardiologiia; 1974 Nov; 14(11):31-40. PubMed ID: 4279310
[No Abstract] [Full Text] [Related]
14. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Scarabin PY; Aillaud MF; Amouyel P; Evans A; Luc G; Ferrières J; Arveiler D; Juhan-Vague I
Thromb Haemost; 1998 Nov; 80(5):749-56. PubMed ID: 9843166
[TBL] [Abstract][Full Text] [Related]
15. [When will fibrinogen screening become available?].
Ernst E
Dtsch Med Wochenschr; 1991 Dec; 116(49):1888-9. PubMed ID: 1743100
[No Abstract] [Full Text] [Related]
16. [Our experiences with long-term treatment with Pelentan in myocardial infarct].
Argalás K; Rysavý F
Vnitr Lek; 1968 Mar; 14(3):283-90. PubMed ID: 5638966
[No Abstract] [Full Text] [Related]
17. Contribution to the evaluation of long-term anticoagulant treatment in patients after myocardial infarction.
Cihàk J
Rev Czech Med; 1977; 23(3):150-7. PubMed ID: 410082
[No Abstract] [Full Text] [Related]
18. Positive association of the beta fibrinogen H1/H2 gene variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction.
Gardemann A; Schwartz O; Haberbosch W; Katz N; Weiss T; Tillmanns H; Hehrlein FW; Waas W; Eberbach A
Thromb Haemost; 1997 Jun; 77(6):1120-6. PubMed ID: 9241743
[TBL] [Abstract][Full Text] [Related]
19. [Behavior of adhesiveness and aggregability of platelets in subjects with arteriosclerotic angiopathy with predominantly coronary manifestations].
Cajozzo A; Citarrella P; Abbadessa V
Boll Soc Ital Cardiol; 1970; 15(5):323-30. PubMed ID: 5527280
[No Abstract] [Full Text] [Related]
20. [Changes of certain indicators of blood coagulation in patients with coronary arteriosclerosis and hypertensive disease].
Pliutto AM
Lab Delo; 1974; 8(0):465-8. PubMed ID: 4139365
[No Abstract] [Full Text] [Related]
[Next] [New Search]
